Status:
COMPLETED
Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions:
Metastatic Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Systemic chemotherapy for metastatic colon cancer is often used in the neoadjuvant setting for patients undergoing liver resection. This treatment is given either to keep the tumor at bay or reduce it...
Eligibility Criteria
Inclusion
- Patients must be ≥ 18 years old.
- Patients must have colon cancer metastases to the liver.
- Patients must be candidates and be scheduled for liver resection.
- Patients must have received and have had a response to neoadjuvant therapy prior to liver resection.
- Patients must have signed Institutional Review Board (IRB) approved written consent form prior to registering in the study.
Exclusion
- Patients who are \< 18 years old.
- Patients who do not have colon cancer metastases to the liver.
- Patients who are not surgical candidates.
- Patients who do not schedule or who cancel a liver resection.
- Patients who have not received neoadjuvant therapy.
- Patients who have received neoadjuvant therapy but who have had no response or who have had tumor progression.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00414492
Start Date
December 1 2006
End Date
June 1 2010
Last Update
September 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Medicine
Baltimore, Maryland, United States, 21287